Role for cannabinoid receptors in human proximal tubular hypertrophy

Cellular Physiology and Biochemistry

Volumn 26, Issue 6, 2010, Pages 879-886

  Jenkin, Kayte A ^a   McAinch, Andrew J ^a   Grinfeld, Esther ^a   Hryciw, Deanne H ^a  

^a VICTORIA UNIVERSITY   (Australia)

Author keywords

Cannabinoid receptors; Hypertrophy; Kidney; Proximal tubule

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 4 CHLORO N (3 METHOXYPHENYL)CINNAMAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 55; MESSENGER RNA; O 1918; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY HYPERTROPHY; KIDNEY PROXIMAL TUBULE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; SIGNAL TRANSDUCTION;

EID: 78651236037     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323997     Document Type: Article

References (48)

1. Howlett AC: The cannabinoid receptors. Prostaglandins Other Lipid Mediat 2002;68-69:619-631.
2. Devane WA, Hanus L, Breuer A, Pertwee R G, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258:1946-1949.
3. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D: The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997;389,816-824.
4. Ryberg E, Larsson N, Sjögren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ: The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 2007;152,1092-1101.
5. Osei-Hyiaman D, DePetrillo M, Pacher P, Liu J, Radaeva S, Bátkai S, Harvey-White J, Mackie K, Offertáler L, Wang L, Kunos G: Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 2005;115:1298-1305.
6. Johnson MR, Rice KC, Howlett A, Melvin LS, Herkenham M: The cannabinoid receptor-pharmacologic identification, anatomical localization and cloning. NIDA Res Monogr 1992;119:86-90.
7. Cavuoto P, McAinch AJ, Hatzinikolas G, Janovská A, Game P, Wittert GA:The expression of receptors for endocannabinoids in human and rodent skeletal muscle. Biochem Biophys Res Commun 2007;364:105-110.
8. Sanchez JF, Krause JE, Cortright DN: The distribution and regulation of vanilloid receptor VR1 and VR1 5' splice variant RNA expression in rat. Neuroscience 2001;107:373-381.
9. Rosenbaum T, Gordon-Shaag A, Munari M, Gordon SE: Ca2+/calmodulin modulates TRPV1 activation by capsaicin. J Gen Physiol 2004:123:53-62.
10. Sawzdargo M, Nguyen T, Lee DK, Lynch KR, Cheng R, Heng HH, George SR, O'Dowd BF: Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain. Brain Res Mol Brain Res 1999;64:193-198.
11. Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T: Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun 2007;362:928-934.
12. Guzmán M: Cannabinoids: potential anticancer agents. Nat Rev Cancer 2003;3:745-755.
13. Campbell RK, White JR Jr: More choices than ever before: emerging therapies for type 2 diabetes. Diabetes Edu 2008;34:518-534.
14. Matias I, Wang JW, Moriello AS, Nieves A, Woodward DF, Di Marzo V: Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. Prostaglandins Leukot Essent Fatty Acids 2006;75:413-418.
15. Eknoyan G: Obesity, diabetes, and chronic kidney disease. Curr Diab Rep 2007;7:449-453.
16. Zerbini G, Gabellini D, Maestroni S, Maestroni A: Early renal dysfunctions in type 1 diabetes and pathogenesis of diabetic nephropathy. J Nephrol 2007;20:S19-22.
17. Janiak P, Poirier B, Bidouard J P, Cadrouvele C, Pierre F, Gouraud L, Barbosa I, Dedio J, Maffrand JP, Le Fur G, O'Connor S, Herbert JM: Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats. Kidney Int 2007;72:1345-1357.
18. Barutta F, Corbelli A, Mastrocola R, Gambino R, Di Marzo V, Pinach S, Rastaldi MP, Perin PC, Gruden G: Cannabinoid Receptor 1 blockage ameliorates albuminuria in experimental diabetic nephropathy. Diabetes 2010;59:1046-1054.
19. Hryciw DH, Ekberg J, Ferguson C, Lee A, Wang D, Parton RG, Pollock CA, Yun CC, Poronnik P: Regulation of albumin endocytosis by PSD95/Dlg/ZO-1 (PDZ) scaffolds. Interaction of Na+-H+ exchange regulatory factor-2 with ClC-5. J Biol Chem 2006;281:16068-16077.
20. Wolf G, Schroeder R, Zahner G, Stahl RA, Shankland SJ: High Glucose-Induced Hypertrophy of Mesangial Cells Requires p27Kip1, an Inhibitor of Cyclin-Dependent Kinases. Am J Pathol 2001;158:1091-1100.
21. Fimiani C, Mattocks D, Cavani F, Salzet M, Deutsch DG, Pryor S, Bilfinger TV, Stefano GB: Morphine and Anandamide Stimulate Intracellular Calcium Transients in Human Arterial Endothelial Cells: Coupling to Nitric Oxide Release. Cell Signal 1999;11:189-193. (Pubitemid 29185137)
22. Nieri P, Romiti N, Adinolfi B, Chicca A, Massarelli I, Chieli E: Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells. Br J Pharmacol 2006;148:682-687.
23. Malysz J, Daza AV, Kage K, Grayson GK, Yao BB, Meyer MD, Gopalakrishnan M: Characterization of human cannabinoid CB2 receptor coupled to chimeric G[alpha]qi5 and G[alpha]qo5 proteins. Eur J Pharmacol 2009;603:12-21.
24. Myrdal SE, Steyger PS: TRPV1 regulators mediate gentamicin penetration of cultured kidney cells. Hear Res 2005;204:170-182.
25. Offertáler L, Mo FM, Bátkai S, Liu J, Begg M, Razdan RK, Martin BR, Bukoski RD, Kunos G: Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor. Mol Pharmacol 2003;63:699-705.
26. Nieri P, Romiti N, Adinolfi B, Chicca A, Massarelli I, Chieli E: Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells. Br J Pharmacol 2006;148:682-687.
27. Widmer M, Hanemann CO, Zajicek J: High concentrations of cannabinoids activate apoptosis in human U373MG glioma cells. J Neurosci Res 2008;86:3212-3220.
28. Lim JC, Lim SK, Han HJ, Park SH: Cannabinoid receptor 1 mediates palmitic acid-induced apoptosis via endoplasmic reticulum stress in human renal proximal tubular cells. J Cell Physiol 2010;225:654-663.
29. Luca T, Di Benedetto G, Scuderi MR, Palumbo M, Clementi S, Bernardini R, Cantarella G: The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro. Eur J Pharmacol 2009:616:16-21.
30. Keown OP, Winterburn TJ, Wainwright CL, Macrury SM, Neilson I, Barrett F, Leslie SJ, Megson IL: 2-arachidonyl glycerol activates platelets via conversion to arachidonic acid and not by direct activation of cannabinoid receptors. Br J Clin Pharmacol 2010;70:180-188.
31. Liu C, Su T, Li F, Li L, Qin X, Pan W, Feng F, Chen F, Liao D, Chen L: PI3K/ Akt signaling transduction pathway is involved in rat vascular smooth muscle cell proliferation induced by apelin-13. Acta Biochim Biophys Sin (Shanghai) 2010;42:396-402.
32. Cavuoto P, McAinch AJ, Hatzinikolas G, Cameron-Smith D, Wittert GA: Effects of cannabinoid receptors on skeletal muscle oxidative pathways. Mol Cell Endocrinol 2007;267:63-69.
33. Maccarrone M, Finazzi-Agró A: endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Diff 2003;10:946-955.
34. Kelly DJ, Cox AJ, Tolcos M, Cooper ME, Wilkinson-Berka JL, Gilbert RE: Attenuation of tubular apoptosis by blockage of the renin-angiotensin system in diabetic Ren-2 rats. Kidney Int 2002;61:31-39.
35. Yin H, Chu A, Li W, Wang B, Shelton F, Otero F, Nguyen DG, Caldwell JS, Chen YA: Lipid G protein-coupled receptor ligand identification using beta-arrestin PathHunter assay. J Biol Chem 2009;284:12328-12338.
36. New DC, Wong YH: BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates. FEBS Lett 2003;536:157-160.
37. Fioravanti B, De Felice M, Stucky CL, Medler KA, Luo MC, Gardell LR, Ibrahim M, Malan TP Jr, Yamamura HI, Ossipov MH, King T, Lai J, Porreca F, Vanderah TW: Constitutive Activity at the Cannabinoid CB1 Receptor Is Required for Behavioral Response to Noxious Chemical Stimulation of TRPV1: Antinociceptive Actions of CB1 Inverse Agonists. J Neurosci 2008;28:11593-11602.
38. Godlewski G, Offertáler L, Wagner JA, Kunos G: Receptors for acylethanolamides-GPR55 and GPR119. Prostaglandins Other Lipid Mediat 2009;89:105-111.
39. Johns DG, Behm DJ, Walker DJ, Ao Z, Shapland EM, Daniels DA, Riddick M, Dowell S, Staton PC, Green P, Shabon U, Bao W, Aiyar N, Yue TL, Brown AJ, Morrison AD, Douglas SA: The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. Br J Pharmacol 2007;152:825-831.
40. McHugh D, Hu SS, Rimmerman N, Juknat A, Vogel Z, Walker JM, Bradshaw HB: N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci 2010;11:44.
41. Zoja C, Benigni A, Remuzzi G: Cellular responses to protein overload: key event in renal disease progression. Curr Opin Nephrol Hypertens 2004;13:31-37.
42. Henstridge CM, Balenga NA, Schröder R, Kargl JK, Platzer W, Martini L, Arthur S, Penman J, Whistler JL, Kostenis E, Waldhoer M, Irving AJ: GPR55 ligands promote receptor coupling to multiple signalling pathways. Br J Pharmacol 2010;160:604-614.
43. Kapur A, Zhao P, Sharir H, Bai Y, Caron MG, Barak LS, Abood ME: Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem 2009;284:29817-29827.
44. Sharir H, Abood ME: Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacol Ther 2010;126:301-313.
45. Hsu SS, Huang CJ, Cheng HH, Chou CT, Lee HY, Wang JL, Chen IS, Liu SI, Lu YC, Chang HT, Huang JK, Chen JS, Jan CR: Anamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells. Toxicology 2007;231:21-29.
46. Hart S, Fischer OM, Ullrich A: Cannabinoids Induce Cancer Cell Proliferation via Tumor Necrosis Factor {alpha}-Converting Enzyme (TACE/ ADAM17)-Mediated Transactivation of the Epidermal Growth Factor Receptor. Cancer Res 2204;64:1943-1950.
47. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK: p38 Mitogen-activated Protein Kinase Is a Critical Component of the Redox-sensitive Signaling Pathways Activated by Angiotensin II. J Biol Chem 1998;273:15022- 15029.
48. Wolf G, Ziyadeh FN: Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 1999;56:393-405. (Pubitemid 29353136)